share_log

Surface Oncology | 8-K: Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

SEC ·  May 4, 2023 19:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.